- Home
- BTE vs INVA Comparison
BTE vs INVA Comparison
Compare BTE & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTE
- INVA
- Stock Information
- Founded
- BTE 1993
- INVA 1996
- Country
- BTE Canada
- INVA United States
- Employees
- BTE N/A
- INVA N/A
- Industry
- BTE Meat/Poultry/Fish
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- BTE Consumer Staples
- INVA Health Care
- Exchange
- BTE Nasdaq
- INVA Nasdaq
- Market Cap
- BTE 1.4B
- INVA 1.3B
- IPO Year
- BTE N/A
- INVA 2004
- Fundamental
- Price
- BTE $2.07
- INVA $18.72
- Analyst Decision
- BTE Hold
- INVA Strong Buy
- Analyst Count
- BTE 1
- INVA 3
- Target Price
- BTE $5.50
- INVA $40.33
- AVG Volume (30 Days)
- BTE 34.1M
- INVA 947.9K
- Earning Date
- BTE 07-31-2025
- INVA 08-04-2025
- Dividend Yield
- BTE 3.12%
- INVA N/A
- EPS Growth
- BTE N/A
- INVA N/A
- EPS
- BTE 0.28
- INVA N/A
- Revenue
- BTE $2,327,227,884.00
- INVA $369,844,000.00
- Revenue This Year
- BTE $3.43
- INVA $3.75
- Revenue Next Year
- BTE N/A
- INVA $12.62
- P/E Ratio
- BTE $7.15
- INVA N/A
- Revenue Growth
- BTE 10.55
- INVA 18.70
- 52 Week Low
- BTE $1.36
- INVA $16.67
- 52 Week High
- BTE $3.76
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- BTE 60.18
- INVA 36.02
- Support Level
- BTE $1.90
- INVA $19.35
- Resistance Level
- BTE $2.15
- INVA $20.58
- Average True Range (ATR)
- BTE 0.10
- INVA 0.46
- MACD
- BTE 0.02
- INVA -0.07
- Stochastic Oscillator
- BTE 77.81
- INVA 3.63
About BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.